The global plasma fractionation market size was valued at USD 33.43 billion in 2024 and is anticipated to grow from USD 36.18 billion in 2025 to reach USD 67.96 billion in 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033).

Market Scope and Research Methodology

This report provides an in-depth analysis of the Plasma Fractionation Market at global, regional, and country levels. It examines market size, regional performance, and competitive strategies of leading companies, supported by a SWOT analysis. The study uses a robust methodology combining primary and secondary research with validated forecasting techniques to deliver accurate and reliable market insights.

The main goal of this report is to offer actionable insights into Plasma Fractionation Market trends, growth drivers, and key factors affecting industry performance. It covers market structure, segmentation, and projected market value, while identifying growth opportunities, challenges, and trends shaped by technology, regulations, cost efficiency, and changing consumer demand.

Download Sample Report PDF

https://straitsresearch.com/report/plasma-fractionation-market/request-sample

Regional Insights

The report provides detailed analysis across major regions, including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region is evaluated for Plasma Fractionation Market size, growth trends, trade patterns, and overall industry maturity. This segmentation helps identify competitive strengths and untapped growth potential in each region.

Market Segmentation

1. By Product
   1. Albumin
   2. Immunoglobulins
      1. Intravenous immunoglobulins
      2. Subcutaneous immunoglobulins
      3. Others
   3. Coagulation Factors
      1. Factor VIII
      2. Factor IX
      3. Von Willebrand Factor
      4. Prothrombin Complex Concentrates
      5. Fibrinogen Concentrates
      6. Others
   4. Protease Inhibitors
   5. Others
2. By Method
   1. Centrifugation
   2. Depth Filtration
   3. Chromatography
   4. Others
3. By Application
   1. Neurology
   2. Hematology
   3. Oncology
   4. Immunology
   5. Pulmonology
   6. Others
4. By End Use
   1. Hospitals & Clinics
   2. Clinical Research
   3. Others

Key Market Players

1. Grifols S.A.
2. CSL Limited
3. Takeda Pharmaceutical Company Limited
4. Octapharma AG
5. Kedrion S.p.A
6. LFB S.A.
7. Biotest AG
8. Sanquin
9. Bio Products Laboratory Ltd.
10. Intas Pharmaceuticals Ltd.
11. Grifols, S.A.
12. ADMA Biologics
13. China Biologic Products Holdings Inc.
14. GC Pharma
15. Hualan Bioengineering Co., Ltd.

Download Sample Report PDF

https://straitsresearch.com/report/plasma-fractionation-market/request-sample

Key Questions Answered in the Report

• What is the market overview of the Plasma Fractionation Market?

• What was the market size in 2024?

• What is the projected CAGR during the forecast period?

• Which factors are driving market growth?

• How is the market segmented?

• What strategies are adopted by leading companies?

• Which trends and applications are shaping industry development?

• Who are the top participants in the market?

• What are the key capabilities and product offerings of leading companies?

About Us

Straits Research has over 10 years of experience providing data-driven insights to more than 2,025 organizations worldwide, from startups to global enterprises. Our syndicated research reports cover high-impact industries such as chemicals, food and beverages, healthcare, automotive, technology, aerospace, and defense. We also offer customized research solutions to support strategic decision-making and business growth.